Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Itraconazole in Metastatic Castration-resistant Prostate Cancer
NCT00887458Phase 2Completed
- Sponsor
- Johns Hopkins University
- Start
- Jul 2009
- Primary completion
- May 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of itraconazole in metastatic castration-resistant prostate cancer (mCRPC), sponsored by Johns Hopkins University. Started Jul 2009; status: completed.
02
Drugs
itraconazole
03
Conditions
metastatic castration-resistant prostate cancer (mCRPC)
Beyond the preview
Go deeper on NCT00887458.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00887458.